EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

C3 Levels in Hypertension: A Case–Control Study

Suresh Jaiswal iD, Bhudev Singh Rajput iD, Dhurba Giri iD, Mandira Chhusyabaga iD, Sanju Maharjan iD, Shiv Hari Ghimire

International Journal of Hypertension · 2026-01 · 2026 (1)

DOI: 10.1155/ijhy/2455110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Hypertension, online erschienen am 16.11.2026. Verfasst von Suresh Jaiswal und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Health & Allied Sciences Pokhara University Kaski Nepal pu.edu.np. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pokhara University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is a public health concern associated with various adverse outcomes, but it can be reversed by timely intervention related to hypertension and complement C3. A case–control study was designed to identify the role of C3 in hypertensive people as cases and healthy people as controls. A blood sample was taken for the determination of C3 levels by Mispa i2, and cholesterol and triglycerides were measured by semianalyzers. All the data were analyzed using SPSS 20.0. Out of 75 participants, 25 subjects diagnosed with hypertension and on medication were taken as cases, and 50 subjects with matched age and sex were included as healthy controls. In complement C3 detections, 16 (21.3%) were abnormal, and 59 (78.7%) were normal. In the cholesterol test results, 13 (17.3%) were high, and 62 (82.7%) were normal. In triglyceride test results, 29 (38.7%) were high, and 46 (61.3%) were normal. Systolic blood pressure among cases and controls ( p = 0.05). Complement levels were found to be higher among cases compared to controls ( p = 0.001). In comparison with healthy controls, cases showed lower levels of cholesterol and TG, with the difference in cholesterol being statistically significant ( p = 0.05). The association of complement with the case and control of the study was found to be significant with a value of p ≤ 0.001, and the odds ratio was estimated as 10.615 at 95% CI (2.927–38.495). C3, cholesterol level, and triglyceride level should be monitored in a timely manner to diagnose the status of hypertension for routine diagnosis.

Schlagwörter

Stichwörter der Autor:innen

complement C3hypertensioninflammationpopulation studies

Autor:innen und Institutionen

  • School of Health & Allied Sciences Pokhara University Kaski Nepal pu.edu.np.

ORCID-Profile: Suresh Jaiswal, Bhudev Singh Rajput, Dhurba Giri, Mandira Chhusyabaga, Sanju Maharjan

Förderung

  • Pokhara University

Zitieren

APA

Jaiswal, S., Rajput, B. S., Giri, D., Chhusyabaga, M., Maharjan, S., & Hari Ghimire, S. (2026). C3 Levels in Hypertension: A Case–Control Study. International Journal of Hypertension, 2026(1). https://doi.org/10.1155/ijhy/2455110

Vancouver

Jaiswal S, Rajput BS, Giri D, Chhusyabaga M, Maharjan S, Hari Ghimire S. C3 Levels in Hypertension: A Case–Control Study. International Journal of Hypertension. 2026;2026(1). doi:10.1155/ijhy/2455110

BibTeX
@article{Jaiswal2026,
  author = {Jaiswal, Suresh and Rajput, Bhudev Singh and Giri, Dhurba and Chhusyabaga, Mandira and Maharjan, Sanju and Hari Ghimire, Shiv},
  title = {C3 Levels in Hypertension: A Case–Control Study},
  journal = {International Journal of Hypertension},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijhy/2455110}
}
Kostenlos starten →